These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 588827)

  • 1. A comparison of the effects of allylglycine and 2-keto-4-pentenoic acid on cerebral glutamic acid decarboxylase activity and convulsions in mice [proceedings].
    Horton RW; Meldrum BS
    Br J Pharmacol; 1977 Nov; 61(3):477P. PubMed ID: 588827
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of 2-keto-4-pentenoic acid in seizures induced by allylglycine.
    Horton RW
    Biochem Pharmacol; 1978 May; 27(10):1471-7. PubMed ID: 29640
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of brain glutamate decarboxylase by 2-keto-4-pentenoic acid, a metabolite of allylglycine.
    Reingold DF; Orlowski M
    J Neurochem; 1979 Mar; 32(3):907-13. PubMed ID: 430066
    [No Abstract]   [Full Text] [Related]  

  • 4. Penicillin-induced convulsions and inhibition of glutamate decarboxylase [proceedings].
    Charington CB; Taberner PV
    Br J Pharmacol; 1979 May; 66(1):72P. PubMed ID: 454958
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioural effects of allylglycine (2-amino-4-pentenoic acid) and 2-keto-4-pentenoic acid following focal injection into the rat cerebellum and caudate nucleus [proceedings].
    Horton RW; Jenner P; Marsden CD; Meldrum BS; Reavill C
    Br J Pharmacol; 1978 Jun; 63(2):381P. PubMed ID: 667460
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain and blood levels of allylglycine in mice following doses sufficient to inhibit glutamate decarboxylase.
    Taberner PV; Keen P
    J Neurochem; 1977 Sep; 29(3):595-7. PubMed ID: 894313
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gamma-aminobutyric acid system in the cat brain during convulsions].
    Snisar' IA; Orekhov VS; Sytinskiĭ IA
    Vopr Med Khim; 1982; 28(5):60-3. PubMed ID: 7179835
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the convulsant allylglycine (2-amino-4-pentenoic acid) on the activity of glutamic acid decarboxylase and the concentration of GABA in different regions of guinea pig brain.
    Fisher SK; Davies WE
    Biochem Pharmacol; 1976 Aug; 25(16):1881-5. PubMed ID: 962962
    [No Abstract]   [Full Text] [Related]  

  • 9. cis- and trans-Aconitic acids as inhibitors of glutamate decarboxylase.
    Endo A; Kitahara N
    Hoppe Seylers Z Physiol Chem; 1977 Oct; 358(10):1365-8. PubMed ID: 924365
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity of GABA synthesis in human brain to oxygen poisoning.
    Wood JD; Peesker SJ; Rozdilsky B
    Aviat Space Environ Med; 1975 Sep; 46(9):1155-6. PubMed ID: 1164354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.
    Horton RW; Meldrum BS
    Br J Pharmacol; 1973 Sep; 49(1):52-63. PubMed ID: 4207045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconvulsive changes in brain glucose metabolism following drugs inhibiting glutamate decarboxylase.
    Horton RW; Meldrum BS
    J Neurochem; 1976 Apr; 26(4):805-9. PubMed ID: 965969
    [No Abstract]   [Full Text] [Related]  

  • 13. D-and L-stereoisomers of allylglycine: convulsive action and inhibition of brain L-glutamate decarboxylase.
    Orlowski M; Reingold DF; Stanley ME
    J Neurochem; 1977 Feb; 28(2):349-53. PubMed ID: 839217
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of 4-methyl-2-methylenevalerate, a non-metabolizable analogue of 2-ketoisocaproate, on insulin secretion and metabolism in ob/ob mouse pancreatic islets.
    Lenzen S; Panten U
    Experientia; 1982 Sep; 38(9):1041-2. PubMed ID: 6751856
    [No Abstract]   [Full Text] [Related]  

  • 15. Some properties of guinea pig brain glutamate decarboxylase and its inhibition by the convulsant allylglycine (2-amino-4-pentenoic acid).
    Fisher SK; Davies WE
    J Neurochem; 1974 Aug; 23(2):427-33. PubMed ID: 4153560
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of human and mouse brain glutamate decarboxylase by the alpha-keto analogs of cysteine and homocysteine.
    Reingold DF; Orlowski M
    Biochem Pharmacol; 1978; 27(21):2567-70. PubMed ID: 569487
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the central nervous system actions of taurine and N-pivaloyltaurine [proceedings].
    Ahtee L; Halmekoski J; Heinonen H; Koskimies A
    Br J Pharmacol; 1979 Jul; 66(3):480P. PubMed ID: 526757
    [No Abstract]   [Full Text] [Related]  

  • 18. The inhibition of mouse brain glutamate decarboxylase by some structural analogues of L-glutamic acid.
    Taberner PV; Pearce MJ; Watkins JC
    Biochem Pharmacol; 1977 Feb; 26(4):345-9. PubMed ID: 849326
    [No Abstract]   [Full Text] [Related]  

  • 19. Folic acid and the inhibition of brain L-glutamic decarboxylase.
    Tunnicliff G; Ngo TT
    Experientia; 1977 Jan; 33(1):67-8. PubMed ID: 836423
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of brain glutamate decarboxylase. Dead-end and product inhibition studies.
    Bayón A; Possani LD; Rode G; Tapia R
    J Neurochem; 1978 Jun; 30(6):1629-31. PubMed ID: 671008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.